Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion

Abstract Background context Use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance spinal fusion rates. Case reports of soft-tissue swelling, ectopic bone formation, and osteolysis have recently surfaced. It is hypothesized that incorporation of rhBMP-2 within a ca...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The spine journal 2011-06, Vol.11 (6), p.560-567
Hauptverfasser: Majid, Kamran, MD, Tseng, Michael D., MD, Baker, Kevin C., MS, Reyes-Trocchia, Alma, MD, Herkowitz, Harry N., MD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 567
container_issue 6
container_start_page 560
container_title The spine journal
container_volume 11
creator Majid, Kamran, MD
Tseng, Michael D., MD
Baker, Kevin C., MS
Reyes-Trocchia, Alma, MD
Herkowitz, Harry N., MD
description Abstract Background context Use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance spinal fusion rates. Case reports of soft-tissue swelling, ectopic bone formation, and osteolysis have recently surfaced. It is hypothesized that incorporation of rhBMP-2 within a calcium phosphate (CaP) coating may help to localize delivery and mitigate these complications. Purpose To compare the characteristics of posterolateral fusion between rabbits receiving rhBMP-2 delivered via physical adsorption to a collagen sponge or rhBMP-2 incorporated within the physical structure of a CaP coating on a collagen sponge. Study design/setting New Zealand white rabbit model of posterolateral lumbar fusion at L5–L6. Methods Eighteen (18) New Zealand white rabbits underwent posterolateral spinal fusion at L5–L6. Rabbits received bilateral collagen sponges that were either coated with CaP (n=3), coated with CaP and dipped in rhBMP-2 (n=3), coated with a hybrid CaP–rhBMP-2 film (n=6), or coated with a hybrid CaP-rhBMP-2 film and dipped in rhBMP-2 (n=6). Animals were followed weekly with radiographs and were sacrificed at 6 weeks. Fusion masses were further characterized by manual palpation, computed tomography, and histology. Results Radiographic evaluation showed that animals in Group 3 (incorporated BMP) fused at 4 weeks, whereas animals in Group 2 (adsorbed BMP) and Group 4 (incorporated and adsorbed BMP) fused by 6 weeks. Animals that received rhBMP-2 physically adsorbed to the collagen sponge showed extension of the fusion mass beyond the L5–L6 level in 56% of cases and bone resorption in 78%. Histology of fusion masses showed mature bone formation in animals belonging to Groups 2, 3, and 4 and extensive osteoclast recruitment in animals belonging to Groups 2 and 4. Conclusions Delivery of rhBMP-2 via incorporation within CaP coatings results in increased rates of radiographic fusion. The burst release profile of rhBMP-2 adsorbed to surfaces, although effective in achieving fusion, may result in increased osteoclast recruitment.
doi_str_mv 10.1016/j.spinee.2009.12.006
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_875488999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1529943009011206</els_id><sourcerecordid>875488999</sourcerecordid><originalsourceid>FETCH-LOGICAL-c416t-d38a85b991f2e34f0ba3fa0653bba109f2af9e6abdd110c2a29c39040ece2b253</originalsourceid><addsrcrecordid>eNqFkUtv1TAQhSMEog_4Bwh5xyphxnnceIMEFVCkSl3Qri3HmbS-JHbwJJXuv6_DLSzYdGXLc87M-DtZ9g6hQMDm477g2XmiQgKoAmUB0LzITrHdtTk2pXyZ7rVUuapKOMnOmPcA0O5Qvs5ONsuuweY0oy8uTG6ixVlhzWjdOon5PvB8bxYSNpjF-TsWhkUXPIkpxFS9I__HMMewkPOip9E9UDwIPvBCE4v0ti1nRjGs7IJ_k70azMj09uk8z26_fb25uMyvrr__uPh8ldsKmyXvy9a0dacUDpLKaoDOlIOBpi67ziCoQZpBUWO6vkcEK41UtlRQAVmSnazL8-zDsW_a7PdKvOjJsaVxNJ7Cyrrd1VXbKqWSsjoqbQzMkQY9RzeZeNAIeuOr9_rIV2-wNEqd-Cbb-6cBazdR_8_0F2gSfDoKKH3zwVHUbB15S72LZBfdB_fchP8b2NF5l7L5RQfifVhj4soaNSeD_rllvEUMChBlavAI0A2laA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>875488999</pqid></control><display><type>article</type><title>Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Majid, Kamran, MD ; Tseng, Michael D., MD ; Baker, Kevin C., MS ; Reyes-Trocchia, Alma, MD ; Herkowitz, Harry N., MD</creator><creatorcontrib>Majid, Kamran, MD ; Tseng, Michael D., MD ; Baker, Kevin C., MS ; Reyes-Trocchia, Alma, MD ; Herkowitz, Harry N., MD</creatorcontrib><description>Abstract Background context Use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance spinal fusion rates. Case reports of soft-tissue swelling, ectopic bone formation, and osteolysis have recently surfaced. It is hypothesized that incorporation of rhBMP-2 within a calcium phosphate (CaP) coating may help to localize delivery and mitigate these complications. Purpose To compare the characteristics of posterolateral fusion between rabbits receiving rhBMP-2 delivered via physical adsorption to a collagen sponge or rhBMP-2 incorporated within the physical structure of a CaP coating on a collagen sponge. Study design/setting New Zealand white rabbit model of posterolateral lumbar fusion at L5–L6. Methods Eighteen (18) New Zealand white rabbits underwent posterolateral spinal fusion at L5–L6. Rabbits received bilateral collagen sponges that were either coated with CaP (n=3), coated with CaP and dipped in rhBMP-2 (n=3), coated with a hybrid CaP–rhBMP-2 film (n=6), or coated with a hybrid CaP-rhBMP-2 film and dipped in rhBMP-2 (n=6). Animals were followed weekly with radiographs and were sacrificed at 6 weeks. Fusion masses were further characterized by manual palpation, computed tomography, and histology. Results Radiographic evaluation showed that animals in Group 3 (incorporated BMP) fused at 4 weeks, whereas animals in Group 2 (adsorbed BMP) and Group 4 (incorporated and adsorbed BMP) fused by 6 weeks. Animals that received rhBMP-2 physically adsorbed to the collagen sponge showed extension of the fusion mass beyond the L5–L6 level in 56% of cases and bone resorption in 78%. Histology of fusion masses showed mature bone formation in animals belonging to Groups 2, 3, and 4 and extensive osteoclast recruitment in animals belonging to Groups 2 and 4. Conclusions Delivery of rhBMP-2 via incorporation within CaP coatings results in increased rates of radiographic fusion. The burst release profile of rhBMP-2 adsorbed to surfaces, although effective in achieving fusion, may result in increased osteoclast recruitment.</description><identifier>ISSN: 1529-9430</identifier><identifier>EISSN: 1878-1632</identifier><identifier>DOI: 10.1016/j.spinee.2009.12.006</identifier><identifier>PMID: 20097616</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Animal model ; Animals ; Biomimetic Materials - therapeutic use ; Bone graft substitute ; Bone Morphogenetic Protein 2 - administration &amp; dosage ; Calcium phosphate ; Calcium Phosphates - administration &amp; dosage ; Coated Materials, Biocompatible - therapeutic use ; Drug delivery ; Drug Delivery Systems - methods ; Humans ; Orthopedics ; Rabbits ; Recombinant Proteins - administration &amp; dosage ; rhBMP-2 ; Spinal Fusion - methods ; Surgical Sponges ; Transforming Growth Factor beta - administration &amp; dosage</subject><ispartof>The spine journal, 2011-06, Vol.11 (6), p.560-567</ispartof><rights>Elsevier Inc.</rights><rights>2011 Elsevier Inc.</rights><rights>Copyright © 2011 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c416t-d38a85b991f2e34f0ba3fa0653bba109f2af9e6abdd110c2a29c39040ece2b253</citedby><cites>FETCH-LOGICAL-c416t-d38a85b991f2e34f0ba3fa0653bba109f2af9e6abdd110c2a29c39040ece2b253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.spinee.2009.12.006$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,781,785,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20097616$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Majid, Kamran, MD</creatorcontrib><creatorcontrib>Tseng, Michael D., MD</creatorcontrib><creatorcontrib>Baker, Kevin C., MS</creatorcontrib><creatorcontrib>Reyes-Trocchia, Alma, MD</creatorcontrib><creatorcontrib>Herkowitz, Harry N., MD</creatorcontrib><title>Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion</title><title>The spine journal</title><addtitle>Spine J</addtitle><description>Abstract Background context Use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance spinal fusion rates. Case reports of soft-tissue swelling, ectopic bone formation, and osteolysis have recently surfaced. It is hypothesized that incorporation of rhBMP-2 within a calcium phosphate (CaP) coating may help to localize delivery and mitigate these complications. Purpose To compare the characteristics of posterolateral fusion between rabbits receiving rhBMP-2 delivered via physical adsorption to a collagen sponge or rhBMP-2 incorporated within the physical structure of a CaP coating on a collagen sponge. Study design/setting New Zealand white rabbit model of posterolateral lumbar fusion at L5–L6. Methods Eighteen (18) New Zealand white rabbits underwent posterolateral spinal fusion at L5–L6. Rabbits received bilateral collagen sponges that were either coated with CaP (n=3), coated with CaP and dipped in rhBMP-2 (n=3), coated with a hybrid CaP–rhBMP-2 film (n=6), or coated with a hybrid CaP-rhBMP-2 film and dipped in rhBMP-2 (n=6). Animals were followed weekly with radiographs and were sacrificed at 6 weeks. Fusion masses were further characterized by manual palpation, computed tomography, and histology. Results Radiographic evaluation showed that animals in Group 3 (incorporated BMP) fused at 4 weeks, whereas animals in Group 2 (adsorbed BMP) and Group 4 (incorporated and adsorbed BMP) fused by 6 weeks. Animals that received rhBMP-2 physically adsorbed to the collagen sponge showed extension of the fusion mass beyond the L5–L6 level in 56% of cases and bone resorption in 78%. Histology of fusion masses showed mature bone formation in animals belonging to Groups 2, 3, and 4 and extensive osteoclast recruitment in animals belonging to Groups 2 and 4. Conclusions Delivery of rhBMP-2 via incorporation within CaP coatings results in increased rates of radiographic fusion. The burst release profile of rhBMP-2 adsorbed to surfaces, although effective in achieving fusion, may result in increased osteoclast recruitment.</description><subject>Animal model</subject><subject>Animals</subject><subject>Biomimetic Materials - therapeutic use</subject><subject>Bone graft substitute</subject><subject>Bone Morphogenetic Protein 2 - administration &amp; dosage</subject><subject>Calcium phosphate</subject><subject>Calcium Phosphates - administration &amp; dosage</subject><subject>Coated Materials, Biocompatible - therapeutic use</subject><subject>Drug delivery</subject><subject>Drug Delivery Systems - methods</subject><subject>Humans</subject><subject>Orthopedics</subject><subject>Rabbits</subject><subject>Recombinant Proteins - administration &amp; dosage</subject><subject>rhBMP-2</subject><subject>Spinal Fusion - methods</subject><subject>Surgical Sponges</subject><subject>Transforming Growth Factor beta - administration &amp; dosage</subject><issn>1529-9430</issn><issn>1878-1632</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtv1TAQhSMEog_4Bwh5xyphxnnceIMEFVCkSl3Qri3HmbS-JHbwJJXuv6_DLSzYdGXLc87M-DtZ9g6hQMDm477g2XmiQgKoAmUB0LzITrHdtTk2pXyZ7rVUuapKOMnOmPcA0O5Qvs5ONsuuweY0oy8uTG6ixVlhzWjdOon5PvB8bxYSNpjF-TsWhkUXPIkpxFS9I__HMMewkPOip9E9UDwIPvBCE4v0ti1nRjGs7IJ_k70azMj09uk8z26_fb25uMyvrr__uPh8ldsKmyXvy9a0dacUDpLKaoDOlIOBpi67ziCoQZpBUWO6vkcEK41UtlRQAVmSnazL8-zDsW_a7PdKvOjJsaVxNJ7Cyrrd1VXbKqWSsjoqbQzMkQY9RzeZeNAIeuOr9_rIV2-wNEqd-Cbb-6cBazdR_8_0F2gSfDoKKH3zwVHUbB15S72LZBfdB_fchP8b2NF5l7L5RQfifVhj4soaNSeD_rllvEUMChBlavAI0A2laA</recordid><startdate>20110601</startdate><enddate>20110601</enddate><creator>Majid, Kamran, MD</creator><creator>Tseng, Michael D., MD</creator><creator>Baker, Kevin C., MS</creator><creator>Reyes-Trocchia, Alma, MD</creator><creator>Herkowitz, Harry N., MD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20110601</creationdate><title>Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion</title><author>Majid, Kamran, MD ; Tseng, Michael D., MD ; Baker, Kevin C., MS ; Reyes-Trocchia, Alma, MD ; Herkowitz, Harry N., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c416t-d38a85b991f2e34f0ba3fa0653bba109f2af9e6abdd110c2a29c39040ece2b253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animal model</topic><topic>Animals</topic><topic>Biomimetic Materials - therapeutic use</topic><topic>Bone graft substitute</topic><topic>Bone Morphogenetic Protein 2 - administration &amp; dosage</topic><topic>Calcium phosphate</topic><topic>Calcium Phosphates - administration &amp; dosage</topic><topic>Coated Materials, Biocompatible - therapeutic use</topic><topic>Drug delivery</topic><topic>Drug Delivery Systems - methods</topic><topic>Humans</topic><topic>Orthopedics</topic><topic>Rabbits</topic><topic>Recombinant Proteins - administration &amp; dosage</topic><topic>rhBMP-2</topic><topic>Spinal Fusion - methods</topic><topic>Surgical Sponges</topic><topic>Transforming Growth Factor beta - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Majid, Kamran, MD</creatorcontrib><creatorcontrib>Tseng, Michael D., MD</creatorcontrib><creatorcontrib>Baker, Kevin C., MS</creatorcontrib><creatorcontrib>Reyes-Trocchia, Alma, MD</creatorcontrib><creatorcontrib>Herkowitz, Harry N., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The spine journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Majid, Kamran, MD</au><au>Tseng, Michael D., MD</au><au>Baker, Kevin C., MS</au><au>Reyes-Trocchia, Alma, MD</au><au>Herkowitz, Harry N., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion</atitle><jtitle>The spine journal</jtitle><addtitle>Spine J</addtitle><date>2011-06-01</date><risdate>2011</risdate><volume>11</volume><issue>6</issue><spage>560</spage><epage>567</epage><pages>560-567</pages><issn>1529-9430</issn><eissn>1878-1632</eissn><abstract>Abstract Background context Use of recombinant human bone morphogenetic protein-2 (rhBMP-2) has been shown to enhance spinal fusion rates. Case reports of soft-tissue swelling, ectopic bone formation, and osteolysis have recently surfaced. It is hypothesized that incorporation of rhBMP-2 within a calcium phosphate (CaP) coating may help to localize delivery and mitigate these complications. Purpose To compare the characteristics of posterolateral fusion between rabbits receiving rhBMP-2 delivered via physical adsorption to a collagen sponge or rhBMP-2 incorporated within the physical structure of a CaP coating on a collagen sponge. Study design/setting New Zealand white rabbit model of posterolateral lumbar fusion at L5–L6. Methods Eighteen (18) New Zealand white rabbits underwent posterolateral spinal fusion at L5–L6. Rabbits received bilateral collagen sponges that were either coated with CaP (n=3), coated with CaP and dipped in rhBMP-2 (n=3), coated with a hybrid CaP–rhBMP-2 film (n=6), or coated with a hybrid CaP-rhBMP-2 film and dipped in rhBMP-2 (n=6). Animals were followed weekly with radiographs and were sacrificed at 6 weeks. Fusion masses were further characterized by manual palpation, computed tomography, and histology. Results Radiographic evaluation showed that animals in Group 3 (incorporated BMP) fused at 4 weeks, whereas animals in Group 2 (adsorbed BMP) and Group 4 (incorporated and adsorbed BMP) fused by 6 weeks. Animals that received rhBMP-2 physically adsorbed to the collagen sponge showed extension of the fusion mass beyond the L5–L6 level in 56% of cases and bone resorption in 78%. Histology of fusion masses showed mature bone formation in animals belonging to Groups 2, 3, and 4 and extensive osteoclast recruitment in animals belonging to Groups 2 and 4. Conclusions Delivery of rhBMP-2 via incorporation within CaP coatings results in increased rates of radiographic fusion. The burst release profile of rhBMP-2 adsorbed to surfaces, although effective in achieving fusion, may result in increased osteoclast recruitment.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>20097616</pmid><doi>10.1016/j.spinee.2009.12.006</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1529-9430
ispartof The spine journal, 2011-06, Vol.11 (6), p.560-567
issn 1529-9430
1878-1632
language eng
recordid cdi_proquest_miscellaneous_875488999
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animal model
Animals
Biomimetic Materials - therapeutic use
Bone graft substitute
Bone Morphogenetic Protein 2 - administration & dosage
Calcium phosphate
Calcium Phosphates - administration & dosage
Coated Materials, Biocompatible - therapeutic use
Drug delivery
Drug Delivery Systems - methods
Humans
Orthopedics
Rabbits
Recombinant Proteins - administration & dosage
rhBMP-2
Spinal Fusion - methods
Surgical Sponges
Transforming Growth Factor beta - administration & dosage
title Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-16T11%3A21%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Biomimetic%20calcium%20phosphate%20coatings%20as%20bone%20morphogenetic%20protein%20delivery%20systems%20in%20spinal%20fusion&rft.jtitle=The%20spine%20journal&rft.au=Majid,%20Kamran,%20MD&rft.date=2011-06-01&rft.volume=11&rft.issue=6&rft.spage=560&rft.epage=567&rft.pages=560-567&rft.issn=1529-9430&rft.eissn=1878-1632&rft_id=info:doi/10.1016/j.spinee.2009.12.006&rft_dat=%3Cproquest_cross%3E875488999%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=875488999&rft_id=info:pmid/20097616&rft_els_id=S1529943009011206&rfr_iscdi=true